Oncogenes: the role of DNA tumor viruses in cancer

Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.

Oncogene·2011

Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.

British journal of cancer·2010

Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.

British journal of cancer·2009

The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.

British journal of cancer·2007

Regulation of PTEN transcription by p53.

Molecular cell·2001

Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.

Oncogene·2001

Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer.

Current opinion in oncology·2026

Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer.

Current opinion in oncology·2026

Adjuvant treatments for stage I breast cancers of one centimeter or less.

Current opinion in oncology·2026

Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2-mutated and PALB2-mutated breast cancers.

Current opinion in oncology·2026

Precision medicine for pediatric gliomas.

Current opinion in oncology·2026

Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.

Current opinion in oncology·2026

Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.

CPT: pharmacometrics & systems pharmacology·2026

The Future of all-Comers Trials in the Era of Precision Oncology.

Clinical pharmacology and therapeutics·2026

Tumor Treating Fields Enhance Temozolomide-Associated Growth Suppression in Glioblastoma Cells and Patient-Derived Organoids Through Cell-Cycle Blockade, Apoptosis, and SMAD-Associated Signaling.

CNS neuroscience & therapeutics·2026

MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.

The Biochemical journal·2026

Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).

Journal of Alzheimer's disease : JAD·2026

Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.

Current pharmaceutical design·2026

Related Experiment Videos

Oncogenes: the role of DNA tumor viruses in cancer

Related Concept Videos

Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.

Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.

Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.

The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.

Regulation of PTEN transcription by p53.

Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.

Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer.

Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer.

Adjuvant treatments for stage I breast cancers of one centimeter or less.

Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2-mutated and PALB2-mutated breast cancers.

Precision medicine for pediatric gliomas.

Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.

Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.

The Future of all-Comers Trials in the Era of Precision Oncology.

Tumor Treating Fields Enhance Temozolomide-Associated Growth Suppression in Glioblastoma Cells and Patient-Derived Organoids Through Cell-Cycle Blockade, Apoptosis, and SMAD-Associated Signaling.

MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.

Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).

Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.

Related Experiment Videos

Oncogenes: the role of DNA tumor viruses in cancer

Related Concept Videos

Related Articles